Color, a population genomics and healthcare technology company that counts Apple, Verily and, most recently, Sioux Falls, S.D.-based Sanford Health among its partners, has closed a $75 million funding ...

Genetic tests for cancer can run thousands of dollars, but Color Genomics plans to change that: it's offering testing for the cancer risk variants BRCA1 and BRCA2 — as well as 17 others — for $249, ...

Please provide your email address to receive an email when new articles are posted on . Direct-to-consumer germline testing for cancer predisposition without oversight and guidance can cause anxiety, ...

A virtual tool can facilitate cascade genetic testing for relatives of people with cancer who have pathogenic variants, ...

When the Human Genome Project concluded 21 years ago, it opened the door for genetic testing and a promise for lifesaving screenings and personalized medicine. An innovation that serves as a key ...

Genetic testing can feel overwhelming, especially when faced with terms like "pathogenic variant" or "variant of uncertain significance." Understanding your results is key to making informed health ...